Is streptokinase used for myocardial infarction?
Streptokinase (SK) is a thrombolytic medication and enzyme. As a medication it is used to break down clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism. The type of heart attack it is used in is an ST elevation myocardial infarction (STEMI).
Is streptokinase a thrombolytic?
Streptokinase is a thrombolytic agent that is highly effective in its ability to lyse fibrin clots and restore blood flow to ischemic tissue.
What is the mechanism of action for streptokinase in thrombolytic therapy?
Streptokinase creates an active complex which promotes the cleavage of the Arg/Val bond in plasminogen to form the proteolytic enzyme plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action.
Which drug is used for thrombolysis in case of acute myocardial infarction?
The most commonly used drug for thrombolytic therapy is tissue plasminogen activator (tPA), but other drugs can do the same thing. Ideally, you should receive thrombolytic medicines within the first 30 minutes after arriving at the hospital for treatment. A blood clot can block the arteries to the heart.
How do you give streptokinase to myocardial infarction?
The adult dose of streptokinase for AMI is 1.5 million U in 50 mL of 5% dextrose in water (D5W) given IV over 60 minutes. Allergic reactions force the termination of many infusions before a therapeutic dose can be administered.
What is the difference between alteplase and streptokinase?
Alteplase is a pharmacologic tPA and functions in the same way. Streptokinase: Streptococci produce this substance. When given as a drug, streptokinase works with the body’s own supply of plasminogen. Plasminogen, in the presence of streptokinase, will become plasmin at a fast rate.
What is the difference between streptokinase and tPA?
Natural streptokinase (SK) is isolated and purified from streptococci bacteria. Its lack of fibrin specificity makes it a less desirable thrombolytic drug than tPA compounds because it produces more fibrinogenolysis. Anistreplase (Eminase®) is a complex of SK and plasminogen.
Why thrombolytics are contraindicated in Nstemi?
In NSTEMI the blood flow is present but limited by stenosis. In NSTEMI, thrombolytics must be avoided as there is no clear benefit of their use. If the condition stays stable a cardiac stress test may be offered, and if needed subsequent revascularization will be carried out to restore a normal blood flow.